All Submissions
Comparison of Multigam® IV (5% vs. 10%) in hematological patients with a secondary immunodeficiency to evaluate infusion time, tolerability and satisfaction. A monocentric observational Belgian study.
0 views
0 downloads
Video
PDF
Abstract
0 Datasets
Powered by
Discover more research and events on
morressier.com
Imprint
Terms of Service
Privacy Policy
Accessibility